Skip to Content

Elderly Patients with Mantle Cell Lymphoma Need to be More Intensively Treated

The future for patients with mantle cell lymphoma is to treat patients with novel targeted drugs upfront and also immunotherapy. This also includes elder patients, who have a really worse prognosis, says professor Ingrid Glimelius, Uppsala University, in this MEDtalk from EHA 2024.

Ingrid Glimelius

Få tillgång

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Back to top